903 related articles for article (PubMed ID: 15388289)
21. Pharmacological modulation of leukotriene D(4) attenuates the development of opioid dependence in a mouse model of naloxone-induced opioid withdrawal syndrome.
Rehni AK; Singh I; Singh N; Bansal N; Bansal S; Kumar M
Eur J Pharmacol; 2008 Nov; 598(1-3):51-6. PubMed ID: 18840427
[TBL] [Abstract][Full Text] [Related]
22. Morphine dependence is associated with changes in neuropeptide S receptor expression and function in rat brain.
Ghazal P; Ciccocioppo R; Ubaldi M
Peptides; 2013 Aug; 46():6-12. PubMed ID: 23684726
[TBL] [Abstract][Full Text] [Related]
23. The effects of buprenorphine on fentanyl withdrawal in rats.
Bruijnzeel AW; Marcinkiewcz C; Isaac S; Booth MM; Dennis DM; Gold MS
Psychopharmacology (Berl); 2007 May; 191(4):931-41. PubMed ID: 17211652
[TBL] [Abstract][Full Text] [Related]
24. A non-invasive gating device for continuous drug delivery that allows control over the timing and duration of spontaneous opiate withdrawal.
Azar MR; Ahmed SH; Lintz R; Gutierrez T; Stinus L; Koob GF
J Neurosci Methods; 2004 May; 135(1-2):129-35. PubMed ID: 15020097
[TBL] [Abstract][Full Text] [Related]
25. Effects of fentanyl dose and exposure duration on the affective and somatic signs of fentanyl withdrawal in rats.
Liu J; Pan H; Gold MS; Derendorf H; Bruijnzeel AW
Neuropharmacology; 2008 Oct; 55(5):812-8. PubMed ID: 18634811
[TBL] [Abstract][Full Text] [Related]
26. Antagonism of orexin type 1 receptors in the locus coeruleus attenuates signs of naloxone-precipitated morphine withdrawal in rats.
Azizi H; Mirnajafi-Zadeh J; Rohampour K; Semnanian S
Neurosci Lett; 2010 Oct; 482(3):255-9. PubMed ID: 20667500
[TBL] [Abstract][Full Text] [Related]
27. Effects of acute morphine withdrawal on ultrasonic vocalizations in adult rats: unchanged 50-kHz call rate and altered subtype profile.
Lin YC; Zhao LL; Clarke PBS
Psychopharmacology (Berl); 2018 Jul; 235(7):1945-1953. PubMed ID: 29663018
[TBL] [Abstract][Full Text] [Related]
28. Acute opioid physical dependence in postaddict humans: naloxone dose effects after brief morphine exposure.
Heishman SJ; Stitzer ML; Bigelow GE; Liebson IA
J Pharmacol Exp Ther; 1989 Jan; 248(1):127-34. PubMed ID: 2913267
[TBL] [Abstract][Full Text] [Related]
29. GABA and opioid mechanisms of the central amygdala underlie the withdrawal-potentiated startle from acute morphine.
Cabral A; Ruggiero RN; Nobre MJ; Brandão ML; Castilho VM
Prog Neuropsychopharmacol Biol Psychiatry; 2009 Mar; 33(2):334-44. PubMed ID: 19150477
[TBL] [Abstract][Full Text] [Related]
30. Rapid neuroadaptation in the nucleus accumbens and bed nucleus of the stria terminalis mediates suppression of operant responding during withdrawal from acute opioid dependence.
Criner SH; Liu J; Schulteis G
Neuroscience; 2007 Feb; 144(4):1436-46. PubMed ID: 17161915
[TBL] [Abstract][Full Text] [Related]
31. Spontaneous withdrawal in intermittent morphine administration in rats and mice: effect of clonidine coadministration and sex-related differences.
Allahverdiyev O; Türkmen AZ; Nurten A; Sehirli I; Enginar N
Turk J Med Sci; 2015; 45(6):1380-9. PubMed ID: 26775398
[TBL] [Abstract][Full Text] [Related]
32. Naloxone-precipitated morphine withdrawal induced place aversions: effect of naloxone at 24 hours postmorphine.
Parker LA; Joshi A
Pharmacol Biochem Behav; 1998 Nov; 61(3):331-3. PubMed ID: 9768568
[TBL] [Abstract][Full Text] [Related]
33. Focal kappa-opioid receptor-mediated dependence and withdrawal in the nucleus paragigantocellularis.
Sinchaisuk S; Ho IK; Rockhold RW
Pharmacol Biochem Behav; 2002 Dec; 74(1):241-52. PubMed ID: 12376173
[TBL] [Abstract][Full Text] [Related]
34. Naloxone-precipitated withdrawal causes an increase in impulsivity in morphine-dependent rats.
Harvey-Lewis C; Brisebois AD; Yong H; Franklin KB
Behav Pharmacol; 2015 Apr; 26(3):326-9. PubMed ID: 25350729
[TBL] [Abstract][Full Text] [Related]
35. The ontogeny of mu opiate tolerance and dependence in the rat: antinociceptive and biochemical studies.
Windh RT; Little PJ; Kuhn CM
J Pharmacol Exp Ther; 1995 Jun; 273(3):1361-74. PubMed ID: 7791109
[TBL] [Abstract][Full Text] [Related]
36. Effects of high-dose selegiline on morphine reinforcement and precipitated withdrawal in dependent rats.
Grasing K; He S
Behav Pharmacol; 2005 Feb; 16(1):1-13. PubMed ID: 15706133
[TBL] [Abstract][Full Text] [Related]
37. Phenylmethanesulfonyl fluoride, a serine protease inhibitor, suppresses naloxone-precipitated withdrawal jumping in morphine-dependent mice.
Nemoto W; Sato T; Nakagawasai O; Yaoita F; Silberring J; Tadano T; Tan-No K
Neuropeptides; 2013 Jun; 47(3):187-91. PubMed ID: 23290539
[TBL] [Abstract][Full Text] [Related]
38. Chronic naloxone-induced supersensitivity affects neither tolerance to nor physical dependence on morphine at hypothalamus-pituitary-adrenocortical axis.
Alcaraz C; Vargas ML; Milanés MV
Neuropeptides; 1996 Feb; 30(1):29-36. PubMed ID: 8868296
[TBL] [Abstract][Full Text] [Related]
39. [Behavioural studies during the gestational-lactation period in morphine treated rats].
Sobor M; Timár J; Riba P; Király KP; Al-Khrasani M; Gyarmati Z; Fürst Z
Neuropsychopharmacol Hung; 2013 Dec; 15(4):239-51. PubMed ID: 24380965
[TBL] [Abstract][Full Text] [Related]
40. Slow-sustained delivery of naloxone reduces typical naloxone-induced precipitated opioid withdrawal effects in male morphine-dependent mice.
Lewter LA; Johnson MC; Treat AC; Kassick AJ; Averick S; Kolber BJ
J Neurosci Res; 2022 Jan; 100(1):339-352. PubMed ID: 32772457
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
